SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-064759
Filing Date
2018-12-17
Accepted
2018-12-17 07:06:07
Documents
2
Period of Report
2018-12-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tv509254_8k.htm 8-K 17101
2 EXHIBIT 99.1 tv509254_ex99-1.htm EX-99.1 13663
  Complete submission text file 0001144204-18-064759.txt   32093
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 181237010
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1